Spouting Rock Asset Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,081
Closed -$376K 168
2021
Q2
$376K Buy
6,081
+492
+9% +$25K 0.12% 162
2021
Q1
$272K Buy
+5,589
New +$270K 0.08% 178

Other funds holding OPRX

Spouting Rock Asset Management's OPRX Position: Q3 2021 in Review

Spouting Rock Asset Management sold out of OptimizeRx (OPRX) in Q3 2021, closing a stake of 6,081 shares — an estimated $376K sold.

Spouting Rock Asset Management first reported a position in OPRX in Q1 2021 and held it in 2 quarters. The position peaked at $376K in Q2 2021. 163 funds tracked by Wall St. Rank hold OPRX as of Q3 2021.

  • Spouting Rock Asset Management reported no remaining OptimizeRx position as of Q3 2021 after selling out during the quarter.
  • Spouting Rock Asset Management sold 6,081 OptimizeRx shares in Q3 2021, an estimated $376K.
  • Spouting Rock Asset Management first reported a position in OptimizeRx in Q1 2021 and held it in 2 quarters.
  • Spouting Rock Asset Management's OptimizeRx position peaked at $376K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2021.

Based on Spouting Rock Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.